Previous Article | Next Article ![]()
J. Virol., 06 1996, 4053-4062, Vol 70, No. 6
MC Estable, B Bell, A Merzouki, JS Montaner, MV O'Shaughnessy and IJ Sadowski
Despite extensive in vitro studies identifying a myriad of cellular
transcription factors that bind the human immunodeficiency virus type 1 5'
long terminal repeat (LTR), the relative contribution of these factors to
human immunodeficiency virus type 1 replication in infected individuals
remains obscure. To address this question, we investigated 478 proviral
quasispecies derived from uncultured peripheral blood mononuclear cells of
42 patients representing all stages of infection. In addition to highly
conserved TATA box, SP-1, and NF-kappaB sites, the Ets core and an adjacent
5'-ACYGCTGA-3' motif were extremely conserved. Importantly, the most
frequent naturally occurring length polymorphism (MFNLP) duplicated
5'-ACYGCTGA-3' motifs in LTRs in which this same motif was disrupted or in
LTRs in which a single point mutation to the Ets core ablated binding of
c-Ets 1 and another factor distinct from both c-Ets 1 and Elf 1. The
MFNLP's location was precise (position -121) and surprisingly frequent (38%
of patients) and demarcated LTR Nef-coding sequences from LTR noncoding
sequences that appear to be evolving independently. Aside from these
features, we found no definitive clinical or transcription phenotype common
to all MFNLP LTRs. We also found previously described and novel point
polymorphisms, including some conferring TAR-dependent and TAR- independent
Tat unresponsiveness, and showed that differential binding of nuclear
factor(s) to a TCTAA TATA box variant may be the mechanism for the latter.
Copyright © 1996, American Society for Microbiology
Human immunodeficiency virus type 1 long terminal repeat variants from 42 patients representing all stages of infection display a wide range of sequence polymorphism and transcription activity
Department of Biochemistry and Molecular Biology, Faculty of Medicine, University of British Columbia, Canada, Vancouver.
This article has been cited by other articles:
| J. Bacteriol. | Mol. Cell. Biol. | Microbiol. Mol. Biol. Rev. |
|---|
| Clin. Vaccine Immunol. | ALL ASM JOURNALS |
|---|